Steve Elms Adma Biologics, Inc. (ADMA) insider trading activity

ADMA Quotes by TradingView

Steve Elms is of ADMA BIOLOGICS, INC.. Currently has a direct ownership of 87,330 shares of ADMA, which is worth approximately $1.56 Million. The most recent transaction as insider was on Feb 19, 2025, when has been sold 10,889 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.3K
14.24% 3M change
14.24% 12M change
Total Value Held $1.56 Million

STEVE ELMS Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 19 2025
BUY
Grant, award, or other acquisition
-
10,889 Added 11.09%
87,330 Common Stock
Feb 26 2024
BUY
Grant, award, or other acquisition
-
24,040 Added 23.92%
76,441 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
25,815 Added 33.0%
52,401 Common Stock
Mar 07 2022
BUY
Grant, award, or other acquisition
-
26,586 Added 50.0%
26,586 Common Stock

Also insider at

ELEV
Elevation Oncology, Inc. Healthcare
MRKR
Marker Therapeutics, Inc. Healthcare
Director
ZSANQ
Zosano Pharma Corp
Director
SE

Steve Elms

New York, NY

Track Institutional and Insider Activities on ADMA

Follow ADMA BIOLOGICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADMA shares.

Notify only if

Insider Trading

Get notified when an Adma Biologics, Inc. insider buys or sells ADMA shares.

Notify only if

News

Receive news related to ADMA BIOLOGICS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADMA